Entero Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENTO and other ETFs, options, and stocks.

About ENTO

Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. 

CEO
Richard Joel Paolone
CEORichard Joel Paolone
Employees
2
Employees2
Headquarters
Boca Raton, Florida
HeadquartersBoca Raton, Florida
Founded
2014
Founded2014
Employees
2
Employees2

ENTO Key Statistics

Market cap
2.24M
Market cap2.24M
Price-Earnings ratio
-0.06
Price-Earnings ratio-0.06
Dividend yield
Dividend yield
Average volume
106.47K
Average volume106.47K
High today
$0.448
High today$0.448
Low today
$0.42
Low today$0.42
Open price
$0.44
Open price$0.44
Volume
186.00K
Volume186.00K
52 Week high
$0.926
52 Week high$0.926
52 Week low
$0.185
52 Week low$0.185

People also own

Based on the portfolios of people who own ENTO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.